Browsing Over 107 Presentations

Sort By
Clinical trial highlights Special session

Live Q&A

Lecture Time
11:05 - 11:15
Speakers
  • Susana Banerjee (London, United Kingdom)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00
GSK - Using biomarkers to guide targeted therapy in gynaecological cancers Industry satellite symposium

How and when should HRD testing guide treatment for 1L advanced ovarian cancer?

Lecture Time
13:32 - 13:49
Speakers
  • Christoph Grimm (Vienna, Austria)
Session Name
GSK - Using biomarkers to guide targeted therapy in gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
13:00 - 14:00
The evolving landscape in cervical cancer treatment Educational session

The role of ADC and other targeted therapies in the treatment or recurrent/metastatic cervical cancer

Lecture Time
09:20 - 09:45
Speakers
  • Nicole Concin (Innsbruck, Austria)
Session Name
The evolving landscape in cervical cancer treatment
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
08:30 - 10:00
Biomarkers in clinical practice and future perspective for gynaecological cancers Special session

Digging into molecular characterization of high-grade ovarian cancer: BRCA, HRD and beyond

Lecture Time
11:10 - 11:30
Speakers
  • Nicole Concin (Innsbruck, Austria)
Session Name
Biomarkers in clinical practice and future perspective for gynaecological cancers
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
10:30 - 12:00
Management of endometrial cancer in the molecular era Educational session

Recent developments in adjuvant treatment

Lecture Time
09:00 - 09:25
Speakers
  • Carien L. Creutzberg (Leiden, Netherlands)
Session Name
Management of endometrial cancer in the molecular era
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
08:30 - 10:00
Closing remarks Welcome and closure

Closing remarks

Lecture Time
17:40 - 17:40
Speakers
  • The Panelists (Valencia, Spain)
Session Name
Closing remarks
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
17:40 - 17:45
Rare gynaecological cancers Educational session

Histo-molecular classification of rare tumours, predictive markers and druggable targets

Lecture Time
16:10 - 16:35
Speakers
  • Iain McNeish (london, United Kingdom)
Session Name
Rare gynaecological cancers
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
16:10 - 17:40
Eisai - Recent advances in the management of endometrial cancer and their impact on the clinical practice Industry satellite symposium

Summary and session close

Lecture Time
18:55 - 19:00
Speakers
  • Ana Oaknin (Barcelona, Spain)
Session Name
Eisai - Recent advances in the management of endometrial cancer and their impact on the clinical practice
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
18:00 - 19:00
Managing the consequences of cancer treatments Clinical case session

Fertility-preservation option in gynaecogical cancer

Lecture Time
14:15 - 14:35
Speakers
  • Frederic Amant (Leuven, Belgium)
Session Name
Managing the consequences of cancer treatments
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
14:15 - 15:45
Mini Oral session Abstract session

Invited Discussant of abstract 20MO

Lecture Time
13:05 - 13:15
Speakers
  • Jean Emmanuel Kurtz (Strasbourg, France)
Session Name
Mini Oral session
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
13:00 - 14:00
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer? Controversy session

Second vote and conclusions

Lecture Time
15:40 - 15:50
Speakers
  • Domenica Lorusso (Rome, Italy)
Session Name
Shall all patients regardless of biomarker status receive immunotherapy in cervical cancer?
Room
Auditorium 1A
Date
Fri, 17.06.2022
Time
14:50 - 15:50
Clinical trial highlights Special session

MITO 23: A randomized phase III trial on trabectedin vs physician choice chemotherapy in BRCA mut and BRCAness ovarian cancer

Lecture Time
11:25 - 11:35
Speakers
  • Domenica Lorusso (Rome, Italy)
Session Name
Clinical trial highlights
Room
Auditorium 1A
Date
Sat, 18.06.2022
Time
10:30 - 12:00